E expression is needed on both bone marrow derived cells and thymic epithelium to increase IL-4 production and achieve protection in NOD bone marrow chimeras

Cytokine

Volumn 11, Issue 10, 1999, Pages 766-772

  Brenden, Nina ^a   Rietz, Cecilia ^a   Böhme, Jan ^b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bone marrow chimeras; Diabetes; IL 4; NOD E

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE; TRANSGENE;

ANIMALIA;

EID: 0032823096     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0482     Document Type: Article

References (31)

1. Castano L, Eisenbarth GS. Type-I Diabetes: A chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol. 8:1990;647-679.
2. Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol. 51:1992;285-322.
3. Hattori M, Buse JB, Jackson RA, Glimcher L, Dorf ME, Minami M, Makino S, Moriwaki K, Kuzuya H, Imura H. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science. 231:1986;733-735.
4. Acha-Orbea H, McDevitt HO. The first external domain of the nonobese diabetic mouse class II I-Aβ chain is unique. Proc Natl Acad Sci. 84:1987;2435-2439.
5. Todd JA, Bell JI, McDevitt HO. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 329:1987;599-604.
6. Nishimoto H, Kikutani H, Yamamura K-I, Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature. 328:1987;432-434.
7. Böhme J, Schuhbaur B, Kanagawa O, Benoist C, Mathis D. MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science. 249:1990;293-295.
8. Lund T, O'Reilly LA, Hutchings PR, Kanagawa O, Simpson E, Gravely R, Chandler P, Dyson PJ, Picard JK, Edwards A. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-Aβ-chain or normal I-Eα-chain. Nature. 345:1990;727-729.
9. ktransgenic mice. Nature. 345:1990;724-726.
10. Parish NM, Acha-Orbea H, Simpson E, Qin S-X, Lund T, Cooke A. A comparative study of T-cell receptor Vβ usage in non-obese diabetic (NOD) and I-E transgenic NOD mice. Immunol. 78:1993;606-610.
11. Charlton B, Lafferty KJ. The Th1/Th2 balance in autoimmunity. Curr Opin Immunol. 7:1995;793-798.
12. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovitch TL. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med. 178:1993;87-99.
13. Mueller R, Krahl T, Sarvetnick N. Pancreatic expression of IL4 abrogates insulitis and autoimmune diabetes in NOD mice. J Exp Med. 184:1996;1093-1099.
14. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mossman TR. Interleukin-10. Annu Rev Immunol. 11:1993;165-190.
15. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol. 71:1994;169-175.
16. Delovitch TL, Singh B. The nonobese diabetic mouse as a model of autoimmune disease: immune dysregulation gets the NOD. Immunity. 7:1997;727-738.
17. Hanson MS, Cetkovic-Cvrlje M, Ramiya VK, Atkinson MA, Maclaren NK, Singh B, Elliott JF, Serreze DV, Leiter EH. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J Immunol. 157:1996;1279-1287.
18. Brenden N, Böhme J. Disease-Protected MHC Ea-transgenic NOD mice show IL-4 production not seen in susceptible Ea-transgenic and non-transgenic NOD mice. Immunology. 95:1998;1-7.
19. van Ewijk W, Ron Y, Monaco JJ, Kappler J, Marrack P, Le Meur M, Gerlinger P, Durand B, Benoist C, Mathis D. Compartmentalization of MHC class II gene expression in transgenic mice. Cell. 53:1988;357-370.
20. Böhme J, Haskins K, Stecha P, van Ewijk W, Le Meur M, Gerlinger P, Benoist C, Mathis D. Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant. Science. 244:1989;1179-1183.
21. Racke MK, Bonomo A, Scott DE. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med. 180:1994;1961-1966.
22. +T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today. 16:1995;34-38.
23. Formby B, Jacobs C, Dubuc P, Shao T. Exogenous administration of IL-1α inhibits active and adoptive transfer autoimmune diabetes in NOD mice. Autoimmunity. 12:1992;21-27.
24. Satoh J, Seino H, Abo T, Tanaka S-I, Shintani S, Ohta S, Tamura K, Sawai T, Nobunaga T, Oteki T. Recombinant human tumor necrosis factor α suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest. 84:1989;1345-1348.
25. Forsgren S, Andersson Å, Hillörn V, Söderström Å, Holmberg D. Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Scand J Immunol. 34:1991;445-451.
26. Georgiou HM, Mandel TE. Reduced incidence of diabetes in nonobese diabetic mice transplanted with thymus from diabetes-resistant donors. Transplant Proc. 24:1992;203-204.
27. Röcken M, Racke M, Shevach EM. IL-4 induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today. 17:1996;225-231.
28. Pilström B, Böhme J. Alleviation of insulitis in NOD mice is associated with expression of transgenic MHC E molecules on primary antigen-presenting cells. Immunology. 90:1997;483-488.
29. Bendelac A, Schwartz RH. Th0 cells in the thymus: the question of T-helper lineages. Immunol Rev. 123:1991;169-188.
30. Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci. 84:1987;1374-1378.
31. Montgomery RA, Dallman MJ. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J Immunol. 147:1991;554-560.